Arcadia Biosciences, Inc.

RKDA • Agricultural Inputs

$0.47

▲ +0.00 (+0.23%)

Current price

EarningsLatest report: Jun 30, 2026

HIGHER-RISK PROFILECautionConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology

Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.

Market Cap

$1.41M

Growth

-24.0%

Cash Flow

0/5

Trend

Negative

Evidence

Manageable debt level · 0Healthy liquidity · 3.09Negative growth trendWeak profitability

Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 21, 2026, 12:21 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$0.47

Change0.23%

Shares Out2.99M

Market Cap$1.41M

Enterprise Value$-2.76M

52W Range0.38 - 6.71

Beta0.55

P/E-0.13

P/S0.30

P/B2.23

P/FCF-0.56

EV/Sales-0.58

Price$0.47

Change0.23%

Shares Out2.99M

Market Cap$1.41M

Enterprise Value$-2.76M

52W Range0.38 - 6.71

Beta0.55

P/E-0.13

P/S0.30

P/B2.23

P/FCF-0.56

EV/Sales-0.58

EV/EBITDA0.68

EV/FCF1.09

Earnings Yield-787.04%

FCF Yield-179.31%

Dividend Yield0.00%

Gross Margin36.23%

Oper. Margin-2.06%

Profit Margin-48.15%

Debt/Eq0.00

Current Ratio3.09

Quick Ratio2.50

Revenue 5Y-24.02%

Target$6.00

Target Upside1169.57%

Target Median$6.00

Target Range6.00 - 6.00

Volume62.41K

Avg Volume3.09M

EPS Surprise-1.31

Investment DNA

How strong this company looks for long-term investors

out of 100

Business Quality

Margins, moat, returns

22/100

Financial Strength

Debt, cash, stability

70/100

Growth Potential

Revenue and expansion

20/100

Price Attractiveness

Cheap or expensive today

95/100

Why this score▼

Manageable debt level · 0Healthy liquidity · 3.09Negative growth trendWeak profitability

Analyst view

Analyst sentiment and price target

RKDA

Analyst sentiment

Based on 5 analyst votes · 2026-09-05

90/100

Bullish

Hold

Bearish

Price Target

2026-08-21

Low

$6.00

Mean

$6.00

Median

$6.00

High

$6.00

Company Overview

IPO: 5/15/2015

Industry: Agricultural Inputs

P/B i: 2.23

Debt / Equity i: 0.00

Operating Margin: -205.74%

Net Margin: -48.15%

ROE i: -

ROIC: -

Financial Health

Score14 / 20

Debt / Equity: 0.00

Current Ratio: 3.09

Quick Ratio: 2.50

Status: Good

Insider Transactions

Recent executive and insider activity

Schaefer Thomas J.

Transaction: 05/09/2025

BUY

Change

+12,500

Price

$3.88

Filing

05/12/2025

Type

BUY

Kawakami Mark

Transaction: 05/09/2025

BUY

Change

+12,500

Price

$3.88

Filing

05/12/2025

Type

BUY

Schaefer Thomas J.

Transaction: 02/03/2025

BUY

Change

+700

Price

$2.49

Filing

02/05/2025

Type

BUY

Insider	Type	Change	Price	Transaction	Filing
Schaefer Thomas J.	BUY	+12,500	$3.88	05/09/2025	05/12/2025
Kawakami Mark	BUY	+12,500	$3.88	05/09/2025	05/12/2025
Schaefer Thomas J.	BUY	+700	$2.49	02/03/2025	02/05/2025
Kawakami Mark	BUY	+700	$2.49	02/03/2025	02/05/2025
Schaefer Thomas J.	BUY	+20,000	$2.71	08/19/2024	08/21/2024
Kawakami Mark	BUY	+20,000	$2.71	08/19/2024	08/21/2024
Comcowich Kevin	BUY	+25,455	$2.71	08/19/2024	08/21/2024
Bolles Albert D.	BUY	+10,909	$2.71	08/19/2024	08/21/2024
Carosella Deborah D	BUY	+10,909	$2.71	08/19/2024	08/21/2024
Murray Lilian Shackelford	BUY	+10,909	$2.71	08/19/2024	08/21/2024
WALLER GREGORY D	BUY	+10,909	$2.71	08/19/2024	08/21/2024
Yoder Amy	BUY	+10,909	$2.71	08/19/2024	08/21/2024
Schaefer Thomas J.	BUY	+700	$2.06	08/01/2024	08/20/2024
Kawakami Mark	BUY	+700	$2.06	08/01/2024	08/20/2024
Kawakami Mark	SELL	-500	$4.68	07/05/2024	07/18/2024
Kawakami Mark	SELL	0	Not reported	07/05/2024	07/18/2024
Schaefer Thomas J.	BUY	+700	$2.06	02/01/2024	02/05/2024
Schaefer Thomas J.	BUY	+649	$3.67	08/04/2023	08/07/2023
Comcowich Kevin	BUY	+2,186	$4.80	06/06/2023	06/16/2023
Murray Lilian Shackelford	BUY	+937	$4.80	06/06/2023	06/16/2023

About the Company

Arcadia Biosciences, Inc.

Arcadia Biosciences, Inc. is a U.S.-based company that provides plant-derived health and well-being products. Additionally, it is actively engaged in agricultural research and development, with a particular focus on improving wheat crops. The aim of these innovations is to enhance farmers' economic stability by boosting crop performance in the field, increasing their value for food and wellness applications, and expanding their potential for industrial uses. Established in 2002, the company's main office is located in Davis, California.

Source - link

Peers

CAPS CNEY ENFY FMSTW GURE INHD ITP NITO QTZM RETO

Size reflects market cap · color matches the chart line

1Y peer performance

Top performers + selected company

Latest news

Analyzing Arcadia Biosciences (NASDAQ:RKDA) & Molson Coors Beverage (NYSE:TAP.A)

Molson Coors Beverage (NYSE: TAP.A - Get Free Report) and Arcadia Biosciences (NASDAQ: RKDA - Get Free Report) are both consumer staples companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, profitability, valuation, institutional ownership, analyst recommendations, risk and dividends. Valuation and Earnings This table compares

Defense World

Arcadia Biosciences (NASDAQ:RKDA) and Kirin (OTCMKTS:KNBWY) Financial Survey

Kirin (OTCMKTS:KNBWY - Get Free Report) and Arcadia Biosciences (NASDAQ: RKDA - Get Free Report) are both consumer staples companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, analyst recommendations, institutional ownership, dividends, valuation and profitability. Analyst Recommendations This is a summary of current

Defense World

Arcadia Biosciences (RKDA) Announces Second Quarter and First Half 2026 Financial Results and Business Highlights

– Net cash used in operating activities only $319K in the second quarter – – Arcadia closes $4 million private placement; ends second quarter with $4.2 million in cash – – July monthly Zola ® sales top $740K; exceed $1 million through first week of August – DALLAS, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative wellness products, today released its financial and business results for the second quarter and first half of 2026.

GlobeNewsWire

Arcadia Biosciences (NASDAQ:RKDA) versus Diageo (NYSE:DEO) Critical Comparison

Diageo (NYSE: DEO - Get Free Report) and Arcadia Biosciences (NASDAQ: RKDA - Get Free Report) are both consumer staples companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, risk, earnings, profitability, analyst recommendations, dividends and valuation. Profitability This table compares Diageo and Arcadia Biosciences'

Defense World

Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

DALLAS, June 12, 2026 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc. (Nasdaq: RKDA), a producer and marketer of innovative wellness products, announced today the closing of its previously announced private placement priced at-the-market under Nasdaq rules for the purchase and sale of 3,883,496 shares of its common stock (or pre-funded warrants in lieu thereof), Series A-1 preferred investment options to purchase up to an aggregate of 3,883,496 shares of common stock and Series A-2 preferred investment options to purchase up to an aggregate of 3,883,496 shares of common stock at a purchase price of $1.

Globe News Wire

Earnings Surprises

Period	Estimate	Actual	Surprise
2026-05-14	-0.8	-2.11	-1.31
2026-03-26	-0.66	-0.98	-0.32
2025-11-07	-0.54	0.62	1.16
2025-08-14	-0.79	0.02	0.81
2025-05-08	-0.98	1.9	2.88
2025-03-20	-0.89	-2.48	-1.59
2024-11-12	-0.77	-0.87	-0.1
2024-08-13	1.55	0.78	-0.77
2024-05-09	-2.52	-1.78	0.74
2024-03-28	-2.68	-2.48	0.2
2023-11-09	-2.67	-1.83	0.84
2023-08-10	-4.92	-2.64	2.28